COGNITION THERAPEUTICS INC (CGTX) Stock Income Statement
NASDAQ:CGTX - US19243B1026 - Common Stock
2.45 USD
-0.16 (-6.13%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 52.94M | 53.97M | 50.72M | 43.55M | 28.60M | |||
| Research and Development | 41.81M | 41.68M | 37.20M | 30.32M | 18.57M | |||
| Selling, General, and Administrative Expenses | 11.13M | 12.29M | 13.53M | 13.23M | 10.03M | |||
| Operating Income | -52.94M | -53.97M | -50.72M | -43.55M | -28.60M | |||
| Interest Income/Expense | -16.00K | -220.00K | -27.00K | -30.00K | 1.32M | |||
| Other Income/Expense | 19.96M | 20.21M | 24.96M | 22.18M | 15.12M | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 440.00K | |||
| Income Before Taxes | -32.99M | -33.97M | -25.79M | -21.40M | -11.72M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -32.99M | -33.97M | -25.79M | -21.40M | -16.25M | |||
| EBITDA | -52.69M | -53.70M | -50.47M | -43.47M | -28.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.66 | -0.85 | -0.86 | -0.91 | -0.72 | |||
| Non GAAP EPS | -0.67 | -0.87 | -0.86 | -0.91 | N/A | |||
| Statistics | ||||||||
All data in USD